These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2337406)

  • 21. Flow cytometric detection of mitotic cells using the bromodeoxyuridine/DNA technique in combination with 90 degrees and forward scatter measurements.
    Nüsse M; Jülch M; Geido E; Bruno S; Di Vinci A; Giaretti W; Ruoss K
    Cytometry; 1989 May; 10(3):312-9. PubMed ID: 2496957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample.
    Eidukevicius R; Characiejus D; Janavicius R; Kazlauskaite N; Pasukoniene V; Mauricas M; Den Otter W
    BMC Cancer; 2005 Sep; 5():122. PubMed ID: 16176590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double labeling of S-phase murine cells with bromodeoxyuridine and a second DNA-specific probe.
    Raza A; Spiridonidis C; Ucar K; Mayers G; Bankert R; Preisler HD
    Cancer Res; 1985 May; 45(5):2283-7. PubMed ID: 3986772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment and characterization of a human ovarian neoplastic cell line, DO-s.
    Briers TW; Stroobants P; Vandeputte TM; Nouwen EJ; Conraads MV; Eestermans G; Van Bockstaele D; De Broe ME
    Cancer Res; 1989 Sep; 49(18):5153-61. PubMed ID: 2548714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In situ immunocytochemical staining of cell colonies growing in plasma clot.
    Bontadini A; Gobbi M; Dinota A; Tazzari PL; Rivano MT; Pileri S
    Histochemistry; 1988; 89(3):237-40. PubMed ID: 3042716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part I: Historical perspectives, histochemical methods and cell kinetics.
    Dolbeare F
    Histochem J; 1995 May; 27(5):339-69. PubMed ID: 7657555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunocytochemical study of the development of the oral cavity in the rat].
    Casasco A; Calligaro A; Marchetti C; Poggi P; Casasco M; Menghini P
    Bull Group Int Rech Sci Stomatol Odontol; 1989 Jan; 32(1):13-7. PubMed ID: 2647169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of 5-bromo-2-deoxyuridine (BrdUrd) incorporation with monoclonal anti-BrdUrd antibody after deoxyribonuclease treatment.
    Takagi S; McFadden ML; Humphreys RE; Woda BA; Sairenji T
    Cytometry; 1993; 14(6):640-8. PubMed ID: 8404370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cell kinetic analysis of human brain tumors by bivariate flow cytometric measurement of cellular DNA content and amount of incorporated bromodeoxyuridine].
    Okuda Y; Taomoto K; Saya H; Ijichi A; Kudo H; Kokunai T; Tamaki N; Matsumoto S
    No To Shinkei; 1989 Apr; 41(4):383-90. PubMed ID: 2765301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunocytochemical labeling of S-phase cells of human tumors by monoclonal antibodies in vitro.
    Hu YQ; Barrows GH
    Chin Med J (Engl); 1988 Apr; 101(4):263-6. PubMed ID: 3138085
    [No Abstract]   [Full Text] [Related]  

  • 31. Lymphoblasts already in the DNA synthesis phase of the cell cycle can be reversibly arrested at the R/G transition.
    Lavoie J; Drouin R
    Chromosoma; 2001 Dec; 110(7):501-10. PubMed ID: 11862457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double labeling and in vitro versus in vivo incorporation of bromodeoxyuridine in patients with acute nonlymphocytic leukemia.
    Raza A; Ucar K; Preisler HD
    Cytometry; 1985 Nov; 6(6):633-40. PubMed ID: 3905302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous triple staining for hypoxia, proliferation, and DNA content in murine tumours.
    Webster L; Hodgkiss RJ; Wilson GD
    Cytometry; 1995 Dec; 21(4):344-51. PubMed ID: 8608732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measurement of the S-phase duration in normal and abnormal human endometrium by in vitro double labelling with bromodeoxyuridine and tritiated thymidine.
    Thornton JG; Wells M; Hume WJ
    J Pathol; 1989 Feb; 157(2):109-15. PubMed ID: 2921671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kinetic heterogeneity of an experimental tumour revealed by BrdUrd incorporation and mathematical modelling.
    Bertuzzi A; Faretta M; Gandolfi A; Sinisgalli C; Starace G; Valoti G; Ubezio P
    Bull Math Biol; 2002 Mar; 64(2):355-84. PubMed ID: 11926121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of bromodeoxyuridine incorporation measurements to the determination of cell distribution within the S phase of the cell cycle.
    Khochbin S; Chabanas A; Albert P; Albert J; Lawrence JJ
    Cytometry; 1988 Sep; 9(5):499-503. PubMed ID: 3180952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Flow cytometric dual-parameter analysis of human leukemic cells using monoclonal anti-BrdUrd antibody].
    Sasaki K; Murakami T; Ogino T; Takahashi M
    Gan No Rinsho; 1985 May; 31(5):549-51. PubMed ID: 3860667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In situ staining of bromodeoxyuridine positive cells in normal and neoplastic colony-forming units grown on plasma clots.
    Tazzari PL; Gobbi M; Tassi C; Lemoli RM; Dinota A; Visani G; Tura S
    J Immunol Methods; 1988 Oct; 113(2):215-9. PubMed ID: 2459254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor cell kinetics using two labels and flow cytometry.
    Ritter MA; Fowler JF; Kim YJ; Gilchrist KW; Morrissey LW; Kinsella TJ
    Cytometry; 1994 May; 16(1):49-58. PubMed ID: 8033734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An improved method for the immunocytochemical detection of bromodeoxyuridine labeled nuclei using flow cytometry.
    Schutte B; Reynders MM; van Assche CL; Hupperets PS; Bosman FT; Blijham GH
    Cytometry; 1987 Jul; 8(4):372-6. PubMed ID: 3113895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.